Dark Star Orchestra Performs Rare Acoustic Show

Dark Star Orchestra with freedomisgreen.com co-founder Jim Bissell (far right)

Just having performed two sold out shows in Reading, Pa and Tarrytown, NY, Dark Star Orchestra played again to another packed house for Mardi Gras at Mexicali Live in Teaneck, NJ last night.

It was a rare acoustic performance and the band played twenty nine songs lasting just over four hours with one set break.

“Where else can you listen to some of the best music on earth in the true spirit of the Grateful Dead?” proclaimed ‘Starhead’ Alex.

He’s right. There are GD cover bands that play the ‘Top 40, but if you were in attendance last night, you heard treasured classics Reuben and Cherise, My Brother Esau, and Mountains of the Moon.

Vocalist Lisa Mackey’s brilliant rendition of Bob Dylan’s Chimes of Freedom was spiritually moving and that was obvious to all those in attendance.  Complemented by Jeff Mattson on lead guitar, her strong vocals resonated throughout the crowd with the heartfelt justice the song deserved.

The Dark Star Orchestra Facebook Page is Here

 

Case Report Shows Dronabinol (Delta9-THC) can Help Autistic Children

dronabinol THC

Dr. René Kurz and Dr. Kurt Blaas published a case report documenting improvements in hyperactivity, lethargy, irritability, stereotypy and inappropriate speech in an autistic child administered dronabinol.*

The authors conclude that this study showed that the use of dronabinol may be able to reduce the symptoms of autism.

To date there have been no other reports of the use of cannabinoids in autism. The authors point to anecdotal data in internet blogs and discussion forums where there are many reports of parents who have tried THC for their autistic children, but without medical monitoring and inappropriate administration.

The abstract is below but you can read the full article here

Abstract

Objective: To evaluate the effectiveness of dronabinol (delta-9-THC) as supplementary therapy in
a child with autistic disorder.

Methods: A child who met the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders)
criteria for a diagnosis of autistic disorder and who took no other medication during the observation
time was included in an open and uncontrolled study. Symptom assessment was performed using the Aberrant Behavior Checklist (ABC) before and after six months of medical treatment.

Result: Compared to baseline, significant improvements were observed for hyperactivity, lethargy,
irritability, stereotypy and inappropriate speech at follow-up (p=0.043).

Conclusion: This study showed that the use of dronabinol may be able to reduce the symptoms of
autism.

Keywords: early infantile autism, autistic disorder, dronabinol, cannabinoid

This article can be downloaded, printed and distributed freely for any non-commercial purposes, provided the original work is properly cited (see copyright info below). Available online at www.cannabis-med.org

Read the full article here

Science Editor Jahan Marcu is currently investigating the pharmacology of cannabinoid receptors. Contact science { at } freedomisgreen.com

* dronabinol is marketed under the name Marinol.

DC, NY and East Coast residents pay highest prices for marijuana

8/31/2011 – Floatingsheep.org released their analysis of the underground marijuana market in the United States. The end result isn’t news to consumers: East Coast residents pay the most for an ounce of pot.

Wired magazine also featured a unique map (see below) that was created from the study data. It compares marijuana prices to the severity of laws. There were some other factors included into the equation, like the distance from Humbolt County, California.

The study centers on prices gathered directly from the public through anonymous online submissions. Thousands of individual reports were sent in through www.priceofweed.com.

Here is their rundown on the average cost of top-shelf marijuana:

Distribution of High Quality Observations by State

Connecticut          Reports= 124   Price = $426.20/oz

Delaware               Reports = 26    Price = $450.00/oz

D.C.                         Reports= 71      Price = $460.70/oz

Florida                  Reports=575    Price = $361.80/oz

Georgia                 Reports = 209  Price = $412.20/oz

Maine                    Reports =  57    Price = $360.00/oz

Maryland             Reports = 162   Price = $436.30/oz

Mass.                    Reports = 368    Price = $416.30/oz

New Hampshire Reports = 58      Price = $407.60/oz

New Jersey         Reports =  198   Price = $412.40/oz

New York            Reports = 876    Price = $416.90/oz

N. Carolina         Reports = 254    Price = $417.90/oz

Pennsylvania     Reports =  400   Price = $414.30/oz

Rhode Island     Reports =71       Price = $419.30/oz

S. Carolina          Reports =  98     Price = $399.00/oz

Vermont             Reports = 61      Price =$393.60/oz

Virginia               Reports =223    Price = $411.90/oz

West Virginia    Reports = 35     Price =$392.80/oz

Read the complete study here.

High Times Magazine has employed a similar method of collecting price information from readers for many years. The monthly “THMQ Pot Prices” column also offers a market analysis of different grades of marijuana and even individual strains.

Again, East Coast readers of HT mag are willing to exchange the most greenbacks for green flowers (with hints of reds, lavenders, oranges and purples). High Times July 2011 THMQ showed Chem Dog selling in New York for an astounding $560 per ounce.

While that was definitely the costliest bud found, many of the THMQs are close match for the floatingsheep.org prices.

Population density, thus simple demand, is a major factor to driving up prices on the East Coast. The severity of laws also tends to bump up the cost as distributors take a greater risk and pass that on to consumers.

Perhaps the most interesting trend for the cost of cannabis has been its stability over the last decade.  There have been moderate increases in the cost of all grades of marijuana. But there has been nothing of a cannabis price bubble compared to other consumer items, like housing, food or gasoline.

Some good news is that several data sources are showing a general decline in marijuana prices. For example the floatingsheep.org study showed that Oregonians pay an average of $255.80 per ounce for high-grade cannabis. So far, those kinds of price reductions have not reached the East Coast.

Chris Goldstein is a respected marijuana reform advocate. As a writer and radio broadcaster he has been covering cannabis news for over a decade. Questions?  [email protected]


CBD and other plant cannabinoids may fight Alzheimers’ disease

New research in The Journal of Molecular Pharmacology demonstrates that Cannabis compounds may be a promising treatment for Alzheimer’s disease. It may seem counter-intuitive that compounds from the Cannabis plant may preserve memory, however Cannabidiol (CBD) and other compounds on the plant have neuroprotective effects. CBD appears to inhibit the cells directly involved with the progression of the disease. Read the new study on cannabinoids and Alzheimer’s disease.

Delaware Medical Marijuana Bill Clears Final Vote

[UPDATE 5/13/2011 – Governor Jack Markell signed the bill into law. DE is now, officially, a medical marijuana state.] 5/11/2011 – “The First State” may become the 16th with a working medical marijuana law. The Delaware Senate passed the amended medical marijuana bill today 17-4. This was the final vote and the bill now heads to Governor Jack Markell’s desk for his signature.

The language creates Compassion Centers within each county for qualifying patients to access up to six ounces of cannabis per month. There are no provisions for home cultivation.

Despite the recent flurry of paper threats from several US Attorneys against medical marijuana programs, more states are moving ahead with bills to legalize them. Medical cannabis dispensaries are also just a signature away from becoming a reality in Vermont.

Activism links:

http://www.mpp.org/states/delaware/

http://www.delawareansformedicalmarijuana.org/

Scientists Uncover How CBD Treats MS, Alters Cholesterol Metabolism

Cannabidiol

5/25/2011 – Cannabidiol (CBD) is a non-psychotropic compound found in the Cannabis plant that is currently being exploited by researchers for its therapeutic properties. CBD is usually the second most abundant compound found in the plant.

A research team devoted to studying the effects of Cannabidiol (CBD) on the immune system has made a series of breakthroughs that may have uncovered a mechanism of CBD’s actions (Kozela 2009, Rimmerman 2011, Juknat 2011). The team may have discovered the specific genes responsible for some of CBD’s therapeutic effects. This type of research could be a big leap forward.

Previously the same team had shown that CBD can effectively treat the symptoms of Multiple Sclerosis in mice. This is in agreement with earlier research published by other labs throughout the world.

This collective body of research demonstrates that CBD that is isolated from the plant (as well as Cannabis preparations containing CBD) have been shown to ameliorate the symptoms of multiple sclerosis in animal models and clinical trials. The effects of CBD on disease progression include decreased inflammation, neuronal protection, and decreased immune cell activity.

In other words, this is even more science that shows how CBD from natural cannabis plants works to treat MS in animals and humans.

Now for the interesting genetic details. CBD can affect the genes Soat2 andCyp27a1, which control sterol metabolism (Ex. Cholesterol). These are part of a larger group of genes, known as stress genes. The well-known cannabinoid THC does not appear to have any effect on these genes.

Anandamide is a natural compound made by mammals from lipids, in a sense it is the “natural THC” found in our brains and throughout the human body. Anandamide and THC act through the cannabinoid receptors and have similar effects. For example THC and Anandamide have similar effects on pain, appetite, and memory.

Special receptors allow THC and Anandamide to work, but CBD does not interact directly with cannabinoid receptors.

Additionally, this research team found that CBD can increase the amount of Anandamide and other important lipids.

There are dozens of cannabinoids in the Cannabis plant. Much attention has been paid to THC over the years because of its euphoric side-effect. Researchers are now very interested in the abilities of CBD because it works so effectively without causing impairment.

Jahan Marcu is currently investigating the pharmacology of cannabinoid receptors. He was working at the California Pacific Medical Center Research Institute when exciting discoveries were made showing enhanced anti-cancer effects with THC and CBD from the Cannabis plant. The findings were published in the Journal of Molecular Cancer Therapeutics. In 2009 he received the Billy Martin Award from the International Cannabinoid Research Society (ICRS). Jahan is currently the vice-chair the Medical and Scientific Advisory Board at Americans for Safe Access (ASA).   Contact:  science { at } freedomisgreen.com

DISCLAIMER: The views and opinions expressed are those of the author and do not necessarily represent any University, business or affiliates. While the information provided in this blog is from published scientific studies it is not intended to diagnose or treat any disease.

Delaware Medical Marijuana Bill Passes Key Vote

5/5/2011 – Despite the recent flurry of paper threats from several US Attorneys against medical marijuana programs, more states are moving ahead with bills to legalize them. Last month the Delaware Senate passed compassionate use legislation and now the House has followed suit. Both floor votes showed strong support. The bill must return to the Senate to finalize some last-minute amendments but the House vote tonight is a good sign that “The First State” may become the 16th with a working medical marijuana law.

From The News Journal

The Delaware House approved use of marijuana for medical purposes today, but tacked on additional restrictions to require the drug is distributed in tamper-proof containers and prohibit smoking cannabis in buses and vehicles.

The House voted 24-17 on Senate Bill 17, which must go back to the Senate for the upper chamber to consider the changes.

The legislation allows Delawareans with cancer, multiple sclerosis, HIV/AIDS, post-traumatic stress disorder and other debilitating diseases to get a doctor’s recommendation to use marijuana to treat their pain, nausea or illness.
Qualified patients would be issued a state identification card.

Three state-regulated not-for-profit dispensaries would be established in each county to sell and distribute medical marijuana to qualified patients and caregivers. READ FULL ARTICLE

Medical marijuana legislation is also pending in New Hampshire, North Carolina, New York, Pennsylvania, Florida and Connecticut … and that’s just on the East Coast.

Activism links:

http://www.mpp.org/states/delaware/

http://www.delawareansformedicalmarijuana.org/

Directory Submissions


Your Name *
Category*
Your Email *
Organization Name *
Org. Description *
Keywords
Org. Website
Org. Phone
Org. Email
  * Provide at least one form of contact.
Org. Address
 
Org. City
Org. State/Province
Org. Zip Code
Org. Country
   
  * required

Powered by Business Directory for WordPress


Clemency Sought from President Obama for Medical Marijuana Advocates

Dr. "Mollie" Fry – Photo by Sharon Letts

On May 2nd, 2011, two medical marijuana heroes – Dr. Marion “Mollie” Fry and her husband Dale Schafer, Esq. will begin five year federal jail terms for manufacturing marijuana and conspiracy to ‘manufacture and distribute cannabis. ‘

Fry, who is a breast cancer survivor, grew her own medicine throughout her chemotherapy and mastectomy. Schafer suffers from complications due to failed back syndrome and hemophilia. Unfortunately, Fry and Schafer will likely endure further medical complications in prison. Obviously, they will be unable to use the most effective therapy, cannabis, and will be at the mercy of the prison healthcare system for pharmaceuticals without an organic choice.

Americans for Safe Access (ASA) has created a form where concerned citizens can ask President Obama to grant clemency to both Mollie and her dear husband, Dale. The Online Action Center also urges the same compassion and sensibility for all medical marijuana patients:

“On Monday, May 2, 2011 our community will lose two more members to the failed war on drugs. Dale Schafer and Dr. Mollie Fry, both patients, must remand themselves into federal custody for participating in bringing medical cannabis to themselves, and to other sick and debilitated community members. How many more will become prisoners of war in the name of medical cannabis? We must urge the federal government to end the raids on our community, but in the meantime we must ask for clemency to be granted to those most affected.”

On the same day, ASA is also holding a Sick and Tired Campaign with a rally at the Department of Justice in Washington DC: “Participation in this campaign will send a clear message to President Obama from the medical cannabis community: We are sick and tired. We are suffering from chronic or debilitating conditions, and we are weary of false promises that do nothing to protect our rights as patients.”

More on Dr. Mollie Cry and Dale Schafer, Esq.’s plight:
Medical Marijuana Providers Dr. Mollie Fry and Dale Schafer Prepare for Prison

Sick and Tired Campaign Poster

Diane Fornbacher has been a cannabis law reform activist for 15 years. Fornbacher is the current Vice Chair of the NORML Women’s Alliance and serves on the board of The Coalition for Medical Marijuana New Jersey (CMMNJ). When she isn’t working to change the cannabis laws she enjoys photography, writing poetry being a mother and performing spoken word with local bands.

Contact: grassroots { at } freedomisgreen.com